iCAD Announces the Appointment of New Members to its Board of Directors
11 janv. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Jan. 11, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today it has...
iCAD Announces Estimated Q4 and Fiscal Year 2021 Revenues
04 janv. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Jan. 04, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, reported select...
iCAD to Participate at the 11th Annual LifeSci Partners Virtual Corporate Access Event
23 déc. 2021 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Dec. 23, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
First Recurrent Glioblastoma Tumor is Treated with Xoft Brain IORT in the United States
14 déc. 2021 08h00 HE
|
iCAD, Inc.
Treatment marks initiation of international multicenter trial evaluating targeted radiation therapy and bevacizumab for the treatment of the most common and aggressive type of malignant brain tumor ...
iCAD to Participate at the Imagine AI + Healthcare Investor Summit
06 déc. 2021 13h39 HE
|
iCAD, Inc.
NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey...
iCAD Announces CEO Transition
06 déc. 2021 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its...
iCAD Announces Compelling New and Real-World Data Demonstrating the Value of ProFound AI to be Presented at RSNA 2021
29 nov. 2021 08h00 HE
|
iCAD, Inc.
World’s first FDA cleared AI breast cancer detection software to be highlighted in three scientific presentations at largest radiological meeting in the world iCAD’s innovative breast health...
iCAD to Participate in the 12th Annual Craig-Hallum Alpha Select Conference
11 nov. 2021 16h05 HE
|
iCAD, Inc.
NASHUA, N.H., Nov. 11, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD to Host 2nd Annual Virtual Investor Webinar on Company’s Innovative Solutions for Cancer Detection and Treatment
11 nov. 2021 08h00 HE
|
iCAD, Inc.
Leading clinical and administrative experts to discuss how leveraging iCAD’s Breast Health Solutions and the Xoft System can enhance clinical efficiency and improve outcomes for patients Webinar...
iCAD Reports Financial Results for the Quarter Ended September 30, 2021
09 nov. 2021 16h05 HE
|
iCAD, Inc.
- Third Quarter Revenues of $9.4 Million Represented 20% Sequential Quarter Growth over the Second Quarter of 2021, Driven by 26% Growth in Detection Revenue and 10% Growth in Therapy Revenue - ...